Directory
>
Peter Bui
Peter Bui
National Chief Director, Cytogenetics | Quest Diagnostics
Carlsbad, California, United States
Peter Bui
Summary
Peter Bui is a seasoned expert in clinical cytogenetics and molecular genetics, currently serving as the National Chief Director of Cytogenetics at Quest Diagnostics. With a solid educational foundation from UCLA, he has amassed extensive experience across various roles in medical diagnostics and research, focusing on cancer and genetic diseases. His dual board certification reflects his commitment to excellence in the field. Peter's career showcases a blend of leadership and technical expertise, having directed significant laboratory operations and training programs. He is passionate about advancing diagnostic techniques to improve patient outcomes. His research has contributed to understanding the molecular mechanisms of cancer, and he is actively engaged in developing innovative diagnostic solutions. Peter's work is characterized by his analytical skills and a deep understanding of biotechnology trends, making him a valuable asset in the life sciences sector.
Peter Bui
Work Experience
National Chief Director, Cytogenetics at
Quest Diagnostics
August 2021 - Present
Clinical Laboratory Director at
INVITAE (SINGAPORE) PTE. LTD.
February 2021 - August 2021
Senior Director, Cytogenetics And Genomics at
Quest Diagnostics
September 2018 - February 2021
Director, Clinical Genomics at
GENOPTIX LTD
April 2016 - September 2018
Clinical Cytogenetics Fellow at
UCLA Health
November 2011 - November 2012
Scientist at
ChromoLogic LLC
March 2011 - October 2011
Research Associate at
CODEXIS LABORATORIES INDIA PRIVATE LIMITED
January 1999 - January 2008
Peter Bui
Education
Frequently Asked Questions about Peter Bui
What is Peter Bui email address?
Peter Bui's primary email address is *********@questdiagnostics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Peter Bui work for?
Peter Bui is a National Chief Director, Cytogenetics at Quest Diagnostics, a company specializing in General Medical & Surgical Hospitals.
Where Peter Bui graduated from?
Peter Bui holds a degree in Microbiology And Molecular Genetics from University of California, Los Angeles.
How can I directly contact Peter Bui?
To contact Peter Bui directly, you can use the email address *********@questdiagnostics.com. Complete contact information is available upon registration with Muraena.
Who is Peter Bui?
Peter Bui is a seasoned expert in clinical cytogenetics and molecular genetics, currently serving as the National Chief Director of Cytogenetics at Quest Diagnostics. With a solid educational foundation from UCLA, he has amassed extensive experience across various roles in medical diagnostics and research, focusing on cancer and genetic diseases. His dual board certification reflects his commitment to excellence in the field. Peter's career showcases a blend of leadership and technical expertise, having directed significant laboratory operations and training programs. He is passionate about advancing diagnostic techniques to improve patient outcomes. His research has contributed to understanding the molecular mechanisms of cancer, and he is actively engaged in developing innovative diagnostic solutions. Peter's work is characterized by his analytical skills and a deep understanding of biotechnology trends, making him a valuable asset in the life sciences sector.
Peter`s contact details
*********@questdiagnostics.com
Colleagues
Executive Director, Health and Wellness Services
Vice President, Total Rewards & Workforce Analytics
Executive Director, Digital Business Transformation
Chief Technologist Blood Bank
Executive Director, Marketing - Health Systems
National Executive Director, Commercial-Quest Advanced Neurology and Blueprint Genetics
Executive Director, Commercial Operations
Vice President Human Resources - Regional Businesses, Commercial, Pathology and Medical Services
Executive Director, Employee Health
Vice President - Corporate HRBP, Employee & Labor Relations COE, HR M&A